TY - JOUR
KW - Adolescent
KW - Adult
KW - Aged
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Cohort Studies
KW - Cross-Sectional Studies
KW - Delivery of Health Care/methods/trends
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment/methods/trends
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pilot Projects
KW - Prevalence
KW - Primary Health Care/methods/trends
KW - Treatment Outcome
KW - United States/epidemiology
KW - Young Adult
KW - buprenorphine
KW - Health Services Research
KW - opioid use disorder
KW - primary care
KW - treatment
AU - G. Lapham
AU - D. M. Boudreau
AU - E. A. Johnson
AU - J. F. Bobb
AU - A. G. Matthews
AU - J. McCormack
AU - D. Liu
AU - J. H. Samet
AU - A. J. Saxon
AU - C. I. Campbell
AU - J. E. Glass
AU - R. C. Rossom
AU - M. T. Murphy
AU - I. A. Binswanger
AU - B. J. H. Yarborough
AU - K. A. Bradley
AU - PROUD Collaborative Investigators
A1 - 
AD - Kaiser Permanente Washington Health Research Institute, United States; University of Washington, Department of Health Services, United States. Electronic address: gwen.t.lapham@kp.org.; Kaiser Permanente Washington Health Research Institute, United States; University of Washington, Department of Pharmacy, United States.; Kaiser Permanente Washington Health Research Institute, United States.; Kaiser Permanente Washington Health Research Institute, United States.; The Emmes Company, United States.; The Emmes Company, United States.; National Institute on Drug Abuse Center for Clinical Trials Network, United States.; Boston University & Boston Medical Center Department of Medicine, Division of General Internal Medicine, United States.; Veteran Affairs Puget Sound Health Care System Center of Excellence in Substance Abuse Treatment and Education, United States; University of Washington, Department of Psychiatry and Behavioral Sciences, United States.; Kaiser Permanente Northern California Division of Research, United States.; Kaiser Permanente Washington Health Research Institute, United States; University of Washington, Department of Psychiatry and Behavioral Sciences, United States.; Health Partners Institute, United States.; Multicare Health System, MultiCare Tacoma Central Family Medicine, United States.; Kaiser Permanente Colorado, Institute for Health Research, United States; Colorado Permanente Medical Group, Denver, CO, United States.; Kaiser Permanente Northwest Center for Health Research, United States.; Kaiser Permanente Washington Health Research Institute, United States; University of Washington, Department of Health Services, United States; University of Washington, Department of Medicine, United States.
BT - Drug and alcohol dependence
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2019.107732
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PY - 2020
SN - 1879-0046; 0376-8716; 0376-8716
SP - 107732
T1 - Prevalence and treatment of opioid use disorders among primary care patients in six health systems
T2 - Drug and alcohol dependence
TI - Prevalence and treatment of opioid use disorders among primary care patients in six health systems
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 31835068
U3 - 10.1016/j.drugalcdep.2019.107732
VL - 207
VO - 1879-0046; 0376-8716; 0376-8716
Y1 - 2020
Y2 - Feb 1
ER -